Home > Insider Trading > Filing (0001104659-19-016424)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1579428	Axsome Therapeutics Inc.	AXSM	Pharmaceutical Preparations (2834)	454241907

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1742143	Nick Pizzie	C/O Axsome Therapeutics, Inc 25 Broadway, 9Th Floor New York NY 10004	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-03-19	60	$12.69	60	No	4	P	Indirect	By UTMA account
Common Stock	Acquisiton	2019-03-19	5,340	$12.58	36,340	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By UTMA account
No	4	P	Direct

Footnotes

Represents 60 shares of common stock purchased by the reporting person as custodian for his son's UTMA account. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The price reported in Column 4 is an average price. These shares were purchased by the reporting person in multiple transactions at prices ranging from $12.57 to $12.59, inclusive. The reporting person undertakes to provide to Axsome Therapeutics, Inc., the staff of the Securities and Exchange Commission, and others pursuant to applicable securities laws, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (2) to this Form 4.